Yes, many groups work with these cells as part of genetic manipulation workflows. In general, gene editing or viral transduction is most efficient at the monocyte or early macrophage stage prior to full M1 polarization, but some protocols can still be adapted post-polarization. Because transduction conditions vary widely, we recommend that you perform a pilot test to optimize MOI, exposure time, and any selection steps.
They are very effective for acute activation studies, where you want a robust pro-inflammatory response following a defined trigger.
If you encounter any difficulties-such as lower-than-expected recovery, morphological changes, or weaker responsiveness to stimuli-our scientific support team is available to help troubleshoot. We can review your workflow, suggest adjustments, and, if necessary, help determine whether a technical replacement may be appropriate.
For Research Use Only. Do Not Use in Food Manufacturing or Medical Procedures (Diagnostics or Therapeutics). Do Not Use in Humans.